In 2005, Atalay et al. [106] demonstrated that in 55 patients with breast cancer, the anti-CENP-B antibody had higher positivity compared to the control group (25 patients), highlighting a possible role of CENPB cancer type [106]. This evidence concerns the gene CENPB and breast carcinoma.